Advancements in Asthma, Immunology, and Allergy Highlighted at ACAAI 2025

Key findings from the annual American College of Allergy, Asthma & Immunology conference in Orlando.

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

The American College of Allergy, Asthma & Immunology (ACAAI) held its annual conference in Orlando, Florida in 2025, featuring the latest advancements in the fields of asthma, immunology, and allergy. Druhan Howell, MD, a leading expert in these areas, provided an overview of some of the most significant research and developments presented at the event.

Why it matters

Asthma, allergies, and immune-related conditions affect millions of people worldwide, and continued research and innovation in these areas can lead to improved treatments and better quality of life for patients. The ACAAI conference is a crucial platform for sharing the latest breakthroughs and insights within the medical community.

The details

Some of the key highlights from the ACAAI 2025 conference included new treatments for severe asthma, advancements in immunotherapy for allergies, and a better understanding of the gut-lung axis and its role in immune function. Researchers also presented findings on the impact of environmental factors, such as air pollution and climate change, on respiratory and allergic conditions.

  • The ACAAI 2025 conference took place in Orlando, Florida in November 2025.

The players

Druhan Howell, MD

A leading expert in the fields of asthma, immunology, and allergy who provided an overview of the key findings presented at the ACAAI 2025 conference.

American College of Allergy, Asthma & Immunology (ACAAI)

A professional medical organization that held its annual conference in Orlando, Florida in 2025, featuring the latest advancements in asthma, immunology, and allergy research and treatment.

Got photos? Submit your photos here. ›

What they’re saying

“The research presented at ACAAI 2025 demonstrates the incredible progress being made in understanding and treating respiratory and immune-related conditions. These advancements have the potential to significantly improve the lives of patients.”

— Druhan Howell, MD (HCPLive)

What’s next

The findings and insights from the ACAAI 2025 conference will likely inform future research and clinical practice in the fields of asthma, immunology, and allergy, leading to the development of new treatments and improved patient outcomes.

The takeaway

The ACAAI 2025 conference highlighted the rapid pace of innovation in the management of respiratory and immune-related conditions, underscoring the importance of continued investment and collaboration in these critical areas of medical research.